2007
DOI: 10.1111/j.1527-3458.2007.00011.x
|View full text |Cite
|
Sign up to set email alerts
|

RB101‐mediated Protection of Endogenous Opioids: Potential Therapeutic Utility?

Abstract: The endogenous opioids met-and leu-enkephalin are inactivated by peptidases preventing the activation of opioid receptors. Inhibition of enkephalin-degrading enzymes increases endogenous enkephalin levels and stimulates robust behavioral effects. RB101, an inhibitor of enkephalin-degrading enzymes, produces antinociceptive, antidepressant, and anxiolytic effects in rodents, without typical opioid-related negative side effects. Although enkephalins are not selective endogenous ligands, RB101 induces these behav… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 58 publications
0
19
0
Order By: Relevance
“…Although the anxiolytic properties of DOR selective agonists have been reported previously (Saitoh et al, 2004;Perrine et al, 2006;Jutkiewicz, 2007), the potential electrophysiological mechanisms by which these effects occur have yet to be investigated. Behaviorally, DOR knock-out mice display greater measures of anxiety than matched controls (Filliol et al, 2000), and selective ␦ antagonists can attenuate the anxiolytic actions of benzodiazepines (Primeaux et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Although the anxiolytic properties of DOR selective agonists have been reported previously (Saitoh et al, 2004;Perrine et al, 2006;Jutkiewicz, 2007), the potential electrophysiological mechanisms by which these effects occur have yet to be investigated. Behaviorally, DOR knock-out mice display greater measures of anxiety than matched controls (Filliol et al, 2000), and selective ␦ antagonists can attenuate the anxiolytic actions of benzodiazepines (Primeaux et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…DOR antinociception to thermal stimuli requires PLC and PKC activation also determines DOR-α2A synergistic effects in the spinal cord (140) . DOR agonists have been increasingly studied for their potential antidepressant and anxiolytic effects in rodent behavioral models (141) . However, it is not yet known how or where DOR agonists mediate antidepressant-like behavioral responses.…”
Section: Opioid Signaling and Behaviormentioning
confidence: 99%
“…The same antagonists administered alone and at a higher dose produce anxiogenic effects (e.g., based on performance in an elevated-plus maze) (Perrine et al, 2006; Saitoh et al, 2004). DORs have further been implicated in normative anxiety regulation, most likely through the action of endogenous opioids (Jutkiewicz, 2007; Nieto et al, 2005). DORs also modulate the anxiolytic effects of the benzodiazepine diazepam.…”
Section: Introductionmentioning
confidence: 99%